3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Breast Neoplasms
39
Neoplasms
37
Depression
29
Prostatic Neoplasms
23
Fatigue
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
15
Multiple Myeloma
15
Lymphoma, Follicular
15
Lymphoma, Large B-Cell, Diffuse
13
Carcinoma, Non-Small-Cell Lung
13
Anxiety Disorders
13
Lymphoma, Mantle-Cell
12
Leukemia, Lymphocytic, Chronic, B-Cell
12
Burkitt Lymphoma
12
Pain
11
Lymphoma, Non-Hodgkin
11
Lymphoma, B-Cell, Marginal Zone
11
Lung Neoplasms
11
Lymphoma, Large-Cell, Immunoblastic
10
Leukemia, Myeloid, Acute
10
Colorectal Neoplasms
10
Leukemia, Myeloid, Chronic-Phase
9
Hodgkin Disease
9
Blast Crisis
9
Vomiting
8
Nausea
8
Lymphoma
8
Leukemia, Myeloid, Accelerated Phase
8
Head and Neck Neoplasms
8
Uterine Cervical Neoplasms
7
Interventions
Therapeutics
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Non Squamous Lung Cancer
×
Therapeutics
×
Clear all
NCT01154140
2017-11-06
PROFILE 1014
Pfizer
Phase 3
Completed
343 enrolled
31 charts